Sp1, a positive regulator of SETDB1, is hyperactivated, while miR-29, a negative regulator of SETDB1 was downregulated in HCC, and they jointly contribute to the high expression of STEDB1 [98]. Here, SETDB1 is linked to hepatocellular carcinoma.